Prostatic Neoplasms
|
group |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
616
|
1
|
0.370 |
None |
1.000 |
4 |
|
2001 |
2010 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
616
|
281
|
0.400 |
None |
0.969 |
4 |
|
2001 |
2019 |
Neoplasms, Experimental
|
phenotype |
Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
66
|
|
0.310 |
None |
1.000 |
2 |
|
2008 |
2014 |
mixed gliomas
|
disease |
Neoplasms
|
Neoplastic Process
|
70
|
|
0.300 |
None |
1.000 |
2 |
|
2006 |
2009 |
Glioma
|
disease |
Neoplasms
|
Neoplastic Process
|
87
|
97
|
0.400 |
None |
0.960 |
2 |
|
1999 |
2019 |
Pathologic Neovascularization
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
6
|
|
0.300 |
None |
1.000 |
2 |
|
2009 |
2010 |
Malignant Glioma
|
disease |
Neoplasms
|
Neoplastic Process
|
70
|
1
|
0.400 |
None |
1.000 |
2 |
|
2000 |
2014 |
Malignant neoplasm of kidney
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
45
|
2
|
0.310 |
None |
1.000 |
1 |
|
2006 |
2008 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
538
|
763
|
0.400 |
None |
0.962 |
1 |
|
2002 |
2019 |
Mammary Carcinoma, Human
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
525
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Endometrial Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
72
|
99
|
0.310 |
None |
1.000 |
1 |
|
2010 |
2018 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
217
|
|
0.400 |
None |
1.000 |
1 |
|
2003 |
2019 |
Malignant neoplasm of pancreas
|
disease |
Digestive System Diseases; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
102
|
42
|
0.400 |
None |
1.000 |
1 |
|
2001 |
2019 |
ovarian neoplasm
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
134
|
547
|
0.380 |
None |
1.000 |
1 |
|
2002 |
2016 |
Malignant neoplasm of ovary
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
137
|
78
|
0.380 |
None |
1.000 |
1 |
|
2001 |
2016 |
Miscarriage
|
disease |
Female Urogenital Diseases and Pregnancy Complications
|
Disease or Syndrome
|
109
|
|
0.310 |
None |
1.000 |
1 |
|
2008 |
2013 |
Early Pregnancy Loss
|
phenotype |
Female Urogenital Diseases and Pregnancy Complications
|
Finding
|
109
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
507
|
203
|
0.400 |
None |
0.967 |
1 |
|
2002 |
2019 |
Acute Myeloid Leukemia (AML-M2)
|
disease |
Neoplasms
|
Neoplastic Process
|
125
|
5
|
0.300 |
None |
1.000 |
1 |
|
2003 |
2003 |
Glioblastoma Multiforme
|
disease |
Neoplasms
|
Neoplastic Process
|
111
|
31
|
0.400 |
None |
0.963 |
1 |
|
2007 |
2019 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
527
|
316
|
0.400 |
None |
1.000 |
1 |
|
2002 |
2018 |
Papillary Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
128
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Collecting Duct Carcinoma of the Kidney
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
128
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Sarcomatoid Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
128
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Chromophobe Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
128
|
2
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |